Evidence map›Paper›PMID 42038727›Full record

ArticleJournal of clinical and translational science2026

Return of results is important to heterogeneous research participants: A single-site survey.

Sheila M O'Byrne, Ismael Castaneda, Rayheann-NaDeja Collins, Dora Ventura, Siddiq Mohamed, Alejandra N Aguirre, Mary Beth Terry, Elizabeth Cohn, Jiying Han, Cheng-Shiun Leu and 6 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sheila M O'ByrneIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.ORCID https://orcid.org/0009-0009-2107-5152
Ismael CastanedaIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Rayheann-NaDeja CollinsIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Dora VenturaIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Siddiq MohamedIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Alejandra N AguirreIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Mary Beth TerryHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, USA.
Elizabeth CohnCity University of New York School of Medicine, USA.
Jiying HanIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.ORCID https://orcid.org/0009-0007-4497-4527
Cheng-Shiun LeuIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Shing M LeeIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.ORCID https://orcid.org/0000-0001-8413-6869
Soumitra SenguptaIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Rhonda G KostCenter for Clinical Translational Science, The Rockefeller University, USA.ORCID https://orcid.org/0000-0002-5419-0589
Karen MarderIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.
Paul S AppelbaumIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.ORCID https://orcid.org/0000-0002-1940-0042
Nancy S GreenIrving Institute for Clinical Translational Science, Columbia University Irving Medical Center, USA.ORCID https://orcid.org/0000-0002-9877-1561

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Empowering the Participant Voice: Collaborative Infrastructure and Validated Tools for Collecting Participant Feedback to Improve the Clinical Research EnterpriseU01TR003206 · NCATS · ROCKEFELLER UNIVERSITY · PI KOST, RHONDA G. · 2020 to 2023
$2.7M
NCATS NIH HHS U01 TR003206NCATS NIH HHS UL1 TR001873
6 · The paper itself

Abstract

Background: Clinical researchers at U.S. academic health centers are becoming more attuned to the perspectives and values of research participants, seeking to partner with them to enhance their satisfaction and improve recruitment strategies. Methodology: We surveyed current or recent participants on their perspectives about the return of study results. Through a multi-site consortium of academic medical centers assessing the experiences of research participants using an online satisfaction survey, we added three questions to our institution's version of the survey to assess the value placed on return of research results (RoR) to current or recent adult participants. Survey participants were offered anonymous participation using four different recruitment mechanisms ("sites") hosted by our institution. Most recruitment was disease-agnostic. Results: A total of 506 heterogeneous respondents completed the survey. Although differences were found across recruitment sites, 73% of all participants desired and 49% expected to receive their own RoR, while 61% expected to receive the study's aggregate results. The importance of receiving their own results was especially salient for respondents from historically underserved communities, identifying as non-white, Latino/Hispanic, primarily Spanish-speaking, older or less educated. Respondents' sex was not a significant factor in preferences for return of results. Conclusions: Our results indicated our research participants' expectations and perceived value of receiving the results from studies in which they participated, especially their individual results. This study provides direct evidence of the desires of our research participant community and suggests that institutional support for the return of study results would better serve participants' interests and expectations in future research.

Indexed as

communitiesresearch ethicsresearch participantsresearch resultsReturn of results

Identifiers

PMID42038727
PMCPMC13107073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.